FONDS JEAN BRACHET POUR LA PROMOTION DE LA RECHERCHE FONDAMENTALE EN BIOLOGIE MOLECULAIRE
0431.334.155 · rovalta.com · 28/09/2026
NORMAL SITUATION
FONDS JEAN BRACHET POUR LA PROMOTION DE LA RECHERCHE FONDAMENTALE EN BIOLOGIE MOLECULAIRE
Company — Normal situation.
Financial year 2023 · Closed on 31/12/2023
Net result106,3 k €+129,9 %over 1 year
Gross margin86,6 k €+323,6 %over 1 year
Equity2 M €+5,7 %over 1 year
Overview
Identity
Source · BCE/KBOFONDS JEAN BRACHET POUR LA PROMOTION DE LA RECHERCHE FONDAMENTALE EN BIOLOGIE MOLECULAIRE is a company registered in Belgium.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0431.334.155
- Legal form
- Non-profit organization
- Latest accounts
- 31/12/2023
Signals
ProfitableSolid equityGood liquidityPositive cashflowPositive EBITDA
Financials
Source · NBB, 8 filingsTrend over 8 financial years
| 2023 | 2022 | 2021 | 2020 | 2019 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 86,6 k € | +324% | -38,7 k € | -50.0% | -25,8 k € | -127% | -11,4 k € | +56.2% | -26 k € |
| EBITDA | 67,2 k € | +121% | -325,8 k € | -942% | -31,3 k € | -109% | -14,9 k € | +54.0% | -32,5 k € |
| Operating result | 67,2 k € | +121% | -325,8 k € | -942% | -31,3 k € | -109% | -14,9 k € | +54.0% | -32,5 k € |
| Net result | 106,3 k € | +130% | -355,1 k € | -328% | 155,9 k € | +108% | 75,1 k € | -58.1% | 179,1 k € |
| Balance sheet | |||||||||
| Equity | 2 M € | +5.7% | 1,9 M € | -15.9% | 2,2 M € | +7.5% | 2,1 M € | +3.8% | 2 M € |
| Total assets | 2 M € | +5.2% | 1,9 M € | -15.7% | 2,2 M € | +7.4% | 2,1 M € | +3.8% | 2 M € |
| Cash | 17,9 k € | -93.6% | 278,1 k € | +22.5% | 227 k € | +572% | 33,8 k € | -96.7% | 1 M € |
| Debts | 6,8 k € | -50.0% | 13,5 k € | +25.4% | 10,8 k € | +115% | 5 k € | -30.0% | 7,1 k € |
Board of directors
Source · NBB, accounts to 31/12/202314 active · 4 ended
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Benoît VANHOLLEBEKE | MandateDirectorended | ||
David PEREZ-MARGA | MandateDirectorended | ||
Dukas JURENAS | Mandate | ||
Elodie DAMIEN | Mandate | ||
Eric BELLEFROID | Mandate | ||
Françoise Magerman | MandateDirectorended | ||
Jacob SOUOPGOU | MandateDirectorended | ||
Laurence Van Melderen | MandateDirectorended | ||
Louis VANHAMME | Mandate | ||
Maud MARTIN | Mandate | ||
Mélanie Boeckstaens | Mandate | ||
Paul BAEKELMANS | MandateChairman of the board of directorsended | ||
Sabrina Bousbata | MandateDirectorended | ||
Véronique KRUYS | MandateDirectorended |
Ended mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Luc VANHAMME | Directorsince 09/09/2019 | ||
Anna Maria MARINI | MandateDirector | ||
Louis DROOGMANS | Mandate |
Financials
Full financial information
Source · NBB| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 | 01/01/2019 | 01/01/2018 |
| Closing of the financial year | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 | 31/12/2018 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 03/07/2024 | 20/07/2023 | 04/10/2022 | 28/10/2021 | 03/11/2020 | 20/09/2019 |
| General meeting | 13/03/2024 | 29/06/2023 | 29/09/2022 | 26/10/2021 | 10/09/2020 | 09/09/2019 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 8 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2023 | 13/03/2024 | 03/07/2024 | French | |
| Abridged model | 31/12/2022 | 29/06/2023 | 20/07/2023 | French | |
| Abridged model | 31/12/2021 | 29/09/2022 | 04/10/2022 | French | |
| Abridged model | 31/12/2020 | 26/10/2021 | 28/10/2021 | French | |
| Abridged model | 31/12/2019 | 10/09/2020 | 03/11/2020 | French | |
| Abridged model | 31/12/2018 | 09/09/2019 | 20/09/2019 | French | |
| Abridged model | 31/12/2017 | 18/06/2018 | 07/08/2018 | French | |
| Abridged model | 31/12/2016 | 19/04/2017 | 07/08/2017 | French |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/202314 active · 4 ended
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Benoît VANHOLLEBEKE | MandateDirectorended | ||
David PEREZ-MARGA | MandateDirectorended | ||
Dukas JURENAS | Mandate | ||
Elodie DAMIEN | Mandate | ||
Eric BELLEFROID | Mandate | ||
Françoise Magerman | MandateDirectorended | ||
Jacob SOUOPGOU | MandateDirectorended | ||
Laurence Van Melderen | MandateDirectorended | ||
Louis VANHAMME | Mandate | ||
Maud MARTIN | Mandate | ||
Mélanie Boeckstaens | Mandate | ||
Paul BAEKELMANS | MandateChairman of the board of directorsended | ||
Sabrina Bousbata | MandateDirectorended | ||
Véronique KRUYS | MandateDirectorended |
Ended mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Luc VANHAMME | Directorsince 09/09/2019 | ||
Anna Maria MARINI | MandateDirector | ||
Louis DROOGMANS | Mandate |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Other29/05/2024Modification du Conseil d'administration
- Mandates24/11/2022DEMISSIONS, NOMINATIONS
- Mandates25/01/2019DEMISSIONS, NOMINATIONS
- Mandates12/03/2018DEMISSIONS, NOMINATIONS
- Mandates03/03/2017DEMISSIONS, NOMINATIONS
- Mandates15/09/2015DEMISSIONS, NOMINATIONS
- Mandates27/10/2014DEMISSIONS, NOMINATIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
- Mandates26/07/2013DEMISSIONS, NOMINATIONS
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsYear
Identity
Name
Registered office
Annual accounts
Filings8 filings
Mandates
Luc VANHAMME
20162017201820192020202120222023202420252026
FONDS JEAN BRACHET POUR LA PROMOTION DE LA RECHERCHE FONDAMENTALE EN BIOLOGIE MOLECULAIRE
Avenue Franklin Roosevelt 50, 1050 Ixelles
CurrentPlanned, not yet servedEndedAccounts filedToday
Registered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Avenue Franklin Roosevelt 50, 1050 Ixelles | accounts 2021 → 2023 | Accounts 2023 · 2024-00203399 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| FONDS JEAN BRACHET POUR LA PROMOTION DE LA RECHERCHE FONDAMENTALE EN BIOLOGIE MOLECULAIRE | accounts 2021 → 2023 | Accounts 2023 · 2024-00203399 |
Events
- 2023Annual accounts 2023106,3 k €↑
- 2022Annual accounts 2022-355,1 k €↓
- 2021Annual accounts 2021155,9 k €↑
- 2020Annual accounts 202075,1 k €↓
- 2019Annual accounts 2019179,1 k €↓
- 2018Annual accounts 20181,8 M €↑
- 2017Annual accounts 201759,9 k €↑
- 2016Annual accounts 2016-461,5 k €